PGC-1α is poorly-expressed in PCOS patients [18] and is involved in the modulation of glucose and lipid metabolism in patients with type 2 DM by mediating the aberrant expression of mitochondrial oxidative phosphorylation (OXPHOS) [19]. This evidence concerns the gene PPARGC1A and polycystic ovary syndrome.